This Academy member benefit temporarily has been made public to allow all practitioners access to content that may assist in patient care during the national pandemic response. Click here for information on joining the Academy. 

Heart Failure

HF: References (2008)

Heart Failure (HF) Evidence-Based Nutrition Practice Guideline

References

[Listed by recommendation.]

HF: Medical Nutrition Therapy and Heart Failure

Arcand JL, Brazel S, Joliffe C, et al, Education by a dietitian in patients with heart failure results in improved adherence with a sodium-restricted diet: A randomized trial. Am Heart J. 2005; 150: 716e1-716e5.

Kuehneman T, Saulsbury D, Splett P, Chapman DB. Demonstrating the impact of nutrition intervention in a heart failure program. J Am Diet Assoc. 2002; 102: 1,790-1,794.

Ramirez EC, Martinez LC, et al. Effects of a Nutritional Intervention on Body Compositiion, Clinical Status, and Quality of Life in Patients with Heart Failure. Nutrition, 2004; 20: 890-895.

HF: Protein Needs and Heart Failure

Aquilani R, Opasich C, Verri M, Boschi F, Febo O, Pasini E, Pastoris O. Is Nutritional Intake Adequate in Chronic Heart Failure Patients? J Am Coll Cardiol. 2003, 42 (7): 1,218-1,223.

Pasini E, Opasich C, Pastoris O, Aquilani R. Inadequate Nutritional Intake for Daily Life Activity of Clinically Stable Patients with Chronic Heart Failure, Am J Cardiol. 2004, 93 (Suppl): 41A-43A.

HF: Energy Needs and Heart Failure

Aquilani R, Opasich C, Verri M, Boschi F, Febo O, Pasini E, Pastoris O. Is Nutritional Intake Adequate in Chronic Heart Failure Patients? J Am Coll Cardiol. 2003, 42 (7): 1,218-1,223.

Obisesan TO, Toth MJ, Poehlman ET, Prediction of resting energy needs in older men with heart failure. Eur J Clin Nutr. 1997 Oct; 51 (10): 678-681.

Pasini E, Opasich C, Pastoris O, Aquilani R. Inadequate Nutritional Intake for Daily Life Activity of Clinically Stable Patients with Chronic Heart Failure, Am J Cardiol. 2004, 93 (Suppl): 41A-43A.

Toth MJ, Gottlieb SS, Fisher ML, Poehlman ET. Daily energy requirements in heart failure patients, Metabolism. 1997; 46 (11): 1,294-1,298.

Toth MJ, Gottlieb SS, Goran MI, Fisher ML, Poehlman ET. Daily energy expenditure in free-living heart failure patients. Am J Physiol. 1997; 272 (Endocrinol Metab. 35): E469-E475.

HF: Sodium and Fluid Restriction and Heart Failure 

Alvelos, M, Ferreira, A, Bettencourt P, et al. The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Failure. 2004; 6: 593-599.

Arcand JL, Brazel S, Joliffe C, et al, Education by a dietitian in patients with heart failure results in improved adherence with a sodium-restricted diet: A randomized trial. Am Heart J. 2005; 150: 716e1-716e5.

Damgaard M, Norsk P et al. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure, Am J Physiol Regul Integr Comp Physiol. 2006, 290: R1294-R1301.

Kuehneman T, Saulsbury D, Splett P, Chapman DB. Demonstrating the impact of nutrition intervention in a heart failure program. J Am Diet Assoc. 2002; 102: 1,790-1,794.

Ramirez EC, Martinez LC, et al. Effects of a Nutritional Intervention on Body Compositiion, Clinical Status, and Quality of Life in Patients with Heart Failure. Nutrition, 2004; 20: 890-895.

Citations Not Used in the Evidence Analysis

Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001; 22: 1,527-1,560.

American College of Cardiology/American Heart Association. 2005 Guideline Update for the Diagnosis and Management for CHF in the Adult. Circulation. 2005; Sept 20: 1-28.

Heart Failure Society of America 2006 Comprehensive Heart Failure Practice Guideline. Journal of Cardiac Failure. 2006; 12. 

HF: Folate, B12 and Heart Failure

Andersson SE, Edvinsson ML, Edvinsson L. Reduction of Homocysteine in Elderly with Heart Failure Improved Vascular Function and Blood Pressure Control but Did Not Affect Inflammatory Activity. Basic & Clin Pharm & Toxicol. 2005; 97: 306-310.

Witte K, Nikitin NP, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J. 2005; 26: 2,238-2,244.

Andersson SE, Edvinsson ML, Edvinsson L. Reduction of Homocysteine in Elderly with Heart Failure Improved Vascular Function and Blood Pressure Control but Did Not Affect Inflammatory Activity. Basic & Clin Pharm & Toxicol. 2005; 97: 306-310.

Witte K, Nikitin NP, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J. 2005; 26: 2,238-2,244.

HF: Thiamine Supplementation and Heart Failure

Pfitzenmeyer et al, Internat J Vit Nutr Res. 1994 64: 113-118.

Shimon et al, Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med. 1995 May; 98 (5): 485-490.

 

Citations Not Used in the Evidence Analysis

 

 

Hunt SA, Abraham WT et. al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 2005; 112.

Natural Medicines Comprehensive Database
http://naturaldatabase.com/(utnmbd455fcmuuiuzbmvtz55)/home.aspx?li=0&st=0&cs=&s=nd.

HF: Magnesium Supplementation and Heart Failure

Ceremuzynski L, Gebalska J, Wolk R, Makowska E. Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation. Journal of Internal Medicine, 2000; 247: 78-86.

Sueta CA, Clarke SW, Dunlap SO, Jensen L, Blauwet MB, Koch G, Patterson JH, Adams KF. Effect of acute magnesium administration on the frequency of ventricular arrhythmias in patients with heart failure. Circulation, 1994; 89: 660-666.

Citations Not Used in the Evidence Analysis 

 

Davey MJ, et. al. A Randomized Controlled Trial of Magnesium Sulfate, in Addition to Usual Care, for Rate Control in Atrial Fibrillation. Ann Emerg Med. 2005; 45: 347-353.

 

HF: Alcohol and Heart Failure

Cooper HA, Exner DV, Domanski MJ. Light-to-Moderate Alcohol Consumption and Prognosis in Patients With Left Ventricular Systolic Dysfunction, J Am Coll Cardiol. 2000, 35: 1,753-1,759.

Fernandez-Sola J, Estruch R, Nicolas, J, Pare J, Saconella E, Antunez E, Urbano-Marquez A. Comparison of alcoholic cardiomyopathy in women versus men. Am J Cardiol. 1997, 80: c481-c485.

Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol Abuse and Dilated Cardiomyopathy in Men, Am J Cardiol. 2000; 85: 1,114-1,118.

Salisbury AC, House JA, Conard MW, Krumholz HM, Spertus JA. Low-to-Moderate Alcohol Intake and Health Status in Heart Failure Patients, J Cardiac Failure. 11 (5): 323-328, 2005.

Citations Not Used in the Evidence Analysis

 

Dietary Guidelines for Americans, 2005
http://www.health.gov/dietaryguidelines/dga2005/report/HTML/D8_Ethanol.htm

 

American Heart Association Guidelines
http://americanheart.org/presenter.jhtml?
.

 

HF: CoEnzyme Q10, L-Arginine, Carnitine and Hawthorn Berry and Heart Failure

Bednarz B, Jaxa-Chamiec T, Gebalska J, Herbaczynska-Cedro K, Ceremuzynski L. L-arginine supplementation prolongs exercise capacity in congestive heart failure. Kardiol Pol. 2004, Apr; 60 (4): 348-353.

Kanaya Y, Nakamura M, Kobayashi N, Hiramori K. Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure. Heart. 1999; 81: 512-517.

Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, Scherez J, Blum M, Laniado S, Iaina A, Keren G. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol. 1995 Nov 1; 26 (5): 1,251-1,256.

Prior DL, Jennings GLR, Chin-Dusting JPF. Transient improvement of acetylcholine responses after short-term oral L-argininen in forearms of human heart failure. J Cardiovascular Pharmacology. 2000; 36: 3-37.

Anand I, Chandrashekhan Y, De Giuli F, Pasini E, Mazzoletti A, Confortini R, Ferrari R. Cardiovasc Drugs Ther. 1998; 12: 291-299.

Rizos I. Three-year survival of patients with heart failure caused by dilatedcardiomyopathy and L-carnitine administration. Am Heart J. 2000 Feb; 139 (2 Pt. 3): S120-123.

Pittler MH, Schmidt K and Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med. 2003 Jun 1; 114 (8): 665-674.

Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators. Molec Aspects Med . 1994, 15 (Suppl): s287-s294.

Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, Vered Y, Vidne BA, Aravot D. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study. Clin Cardiol. 2004, 27: 295-299.

Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW, Gottlieb SS. The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med. 2000,132: 636-640.

Langsjoen H, Langsjoen P, Langsjoen P, Willis R, Folkers K. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study. Molec Aspects Med. 1994; 15 (Suppl): s165-s175.

Ma A, Zhang W, Liu Z. Effect of protection and repair of injury of mitochondrial membrane-phospholipid on prognosis in patients with dilated cardiomyopathy. Blood Pressure, 5 (Suppl 3): 53-55, 1996.

Shekelle P, Morton S, Hardy M. Effect of Supplemental Antioxidants Vitamin C, Vitamin E,and Coenzyme Q10 for the Prevention and Treatment of Cardiovascular Disease. Evidence Report/Technology Assessment, No. 83 (Prepared by Southern California–RAND Evidence Based Practice Center, under Contract No 290-97-0001). AHRQ Publication No. 03-E043. Rockville, MD: Agency for Healthcare Research and Quality. July 2003.

Munkholm H, Hansen HH, Rasmussen K. Coenzyme Q10 treatment in serious heart failure. Biofactors. 1999; 9 (2-4): 285-289

Sacher HL, Sacher ML, Landau SW, Kersten R, Dooley F, Sacher A, Sacher M, Dietrick K, Ichkhan K. The clinical and hemodynamic effects of coenzyme Q10 in congestivecardiomyopathy. Am J Ther. 1997 Feb-Mar; 4 (2-3): 66-72.

Citations Not Used in the Evidence Analysis 

 

Hunt SA, Abraham WT et. al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation. 2005; 112.

 

Natural Medicines Comprehensive Database http://naturaldatabase.com/(utnmbd455fcmuuiuzbmvtz55)/home.aspx?li=0&st=0&cs=&s=nd.